The article discusses the potential for menstrual blood to be used as a diagnostic tool and source of stem cells. Researchers have been exploring ways to use period blood to detect various gynecological disorders, including endometriosis, adenomyosis, chronic endometritis, fibroids, polycystic ovary syndrome, and ovarian and endometrial cancers.
The article highlights several startups and research groups that are working on menstrual blood-based testing, including:
* Qvin, which has received FDA approval for a special menstrual pad and test for women already diagnosed with diabetes to track blood sugar levels.
* Theblood, a German startup that is exploring how to use period blood collected via a menstrual cup to provide women with health status reports.
* ETH Zรผrich in Switzerland, which has unveiled a prototype menstrual pad with a non-electronic sensor that changes color in the presence of certain proteins in menstrual blood that could indicate disease.
The article also mentions that menstrual blood contains stem cells and stem cell-like cells, making it more challenging to isolate a pure, reliable sample. However, researchers believe that this could be an opportunity to develop new therapies for gynecological disorders.
Fundamental work on the potential of menstrual blood is being held back in the US by the lack of funding and the "ick factor" associated with using period blood. The Massachusetts Institute of Technology (MIT) has launched a $10m menstruation science initiative, which could help to address this issue.
The article concludes that while there are many promising developments in the field of menstrual blood-based testing, more research is needed to fully understand its potential and limitations.
The article highlights several startups and research groups that are working on menstrual blood-based testing, including:
* Qvin, which has received FDA approval for a special menstrual pad and test for women already diagnosed with diabetes to track blood sugar levels.
* Theblood, a German startup that is exploring how to use period blood collected via a menstrual cup to provide women with health status reports.
* ETH Zรผrich in Switzerland, which has unveiled a prototype menstrual pad with a non-electronic sensor that changes color in the presence of certain proteins in menstrual blood that could indicate disease.
The article also mentions that menstrual blood contains stem cells and stem cell-like cells, making it more challenging to isolate a pure, reliable sample. However, researchers believe that this could be an opportunity to develop new therapies for gynecological disorders.
Fundamental work on the potential of menstrual blood is being held back in the US by the lack of funding and the "ick factor" associated with using period blood. The Massachusetts Institute of Technology (MIT) has launched a $10m menstruation science initiative, which could help to address this issue.
The article concludes that while there are many promising developments in the field of menstrual blood-based testing, more research is needed to fully understand its potential and limitations.